珠江会议聚焦中医药传承项目发掘

2017-11-20 朱蕗鋆 中国中医

1月16日,国家中医药发展会议(珠江会议)第二十五届学术研讨会在广东省广州市举行。会议旨在落实中医药法第四十二条关于开展中医药学术传承的规定,为如何深入发掘并传承中医药学术理论集思广益。

1月16日,国家中医药发展会议(珠江会议)第二十五届学术研讨会在广东省广州市举行。会议旨在落实中医药法第四十二条关于开展中医药学术传承的规定,为如何深入发掘并传承中医药学术理论集思广益。

中国中医科学院副院长杨龙会就中医药传承项目的定位及内涵外延等做主题发言。与会专家围绕中医药学术传承项目和传承人制度进行研讨并认为,应从更广更深的角度发掘出具有深刻的文化底蕴、重要的学术价值、重要的临床意义和良好的应用前景的传承项目。

会议由科学技术部、国家中医药管理局、广东省人民政府主办,广东省科学技术厅、广东省中医药局、广东省中医药科学院、广东省中医院承办。国家中医药管理局科技司副司长王思成、广东省中医药局副局长李梓廉等出席。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1675556, encodeId=ed7216e555675, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Thu Dec 07 16:11:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409197, encodeId=f094140919ebe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 22 11:11:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262917, encodeId=f9f626291e4d, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Nov 20 21:36:28 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-12-07 lishizhe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1675556, encodeId=ed7216e555675, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Thu Dec 07 16:11:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409197, encodeId=f094140919ebe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 22 11:11:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262917, encodeId=f9f626291e4d, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Nov 20 21:36:28 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-22 cathymary
  3. [GetPortalCommentsPageByObjectIdResponse(id=1675556, encodeId=ed7216e555675, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Thu Dec 07 16:11:00 CST 2017, time=2017-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409197, encodeId=f094140919ebe, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Wed Nov 22 11:11:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262917, encodeId=f9f626291e4d, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Nov 20 21:36:28 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-20 1e1b8538m79(暂无匿称)

    不错的文章值得推荐

    0